Multicenter phase II trial of gefitinib first-line therapy followed by chemotherapy in advanced non-small cell lung cancer (NSCLC): Preliminary results. A study of the Swiss Group for Clinical Cancer Research (SAKK)

G. D’Addario, Daniel Betticher, Roger Stupp et al.|Journal of Clinical Oncology|2005

Cited by 5